Literature DB >> 369835

Alloxan uptake by isolated rat islets of Langerhans.

D C Weaver, M L McDaniel, P E Lacy.   

Abstract

Alloxan inhibits subsequent glucose-induced insulin release from isolated rat islets of Langerhans maintained in vitro. Several agents (D-glucose, D-mannose, 3-0-methyl-D-glucose, caffeine, and cytochalasin B) when present during the alloxan exposure protect against alloxan inhibition of insulin release. To examine the mechanism of alloxan inhibition, the uptake of [2-14C]alloxan was measured in isolated islets. [2-14C]Alloxan was rapidly accumulated by the islets in a time- and temperature-dependent manner. The radio-activity from islets incubated with [2-14C]alloxan was isolated and shown by thin layer chromatography to comigrate with alloxan and alloxanic acid, an alloxan decomposition product. As no uptake of radioactivity occurred in the presence of medium containing the radioactive decomposition product, it was concluded that alloxan enters the intracellular space of the islet and undergoes a subsequent internal decomposition. Some of the protective agents (3-0-methyl-D-glucose, caffeine, and cytochalasin B) partially inhibited alloxan uptake, whereas others (D-glucose and D-mannose) increased the uptake of alloxan. These and other results suggest that the experimental agents do not provide protection against alloxan inhibition by preventing the entry of alloxan into the intracellular space of the islet. The possibility of D-glucose and alloxan competing for a common binding site on the cell membrane is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 369835     DOI: 10.1210/endo-102-6-1847

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  Alloxan: history and mechanism of action.

Authors:  S Lenzen; U Panten
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

2.  Effects of alloxan on glucose-stimulated insulin secretion, glucose metabolism, and cyclic adenosine 3', 5'-monophosphate levels in rat isolated islets of langerhans.

Authors:  W S Zawalich; R C Karl; F M Matschinsky
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

3.  Protective role of superoxide dismutase against diabetogenic drugs.

Authors:  S E Gandy; M G Buse; R K Crouch
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

4.  Selective uptake of alloxan by pancreatic B-cells.

Authors:  F K Gorus; W J Malaisse; D G Pipeleers
Journal:  Biochem J       Date:  1982-11-15       Impact factor: 3.857

5.  Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.

Authors:  A De Vos; H Heimberg; E Quartier; P Huypens; L Bouwens; D Pipeleers; F Schuit
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  The diabetogenic agent alloxan increases K+ permeability by a mechanism involving activation of ATP-sensitive K(+)-channels in mouse pancreatic beta-cells.

Authors:  P B Carroll; A S Moura; E Rojas; I Atwater
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

7.  Inhibition of aconitase by alloxan and the differential modes of protection of glucose, 3-O-methylglucose, and mannoheptulose.

Authors:  S Lenzen; M Mirzaie-Petri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

8.  Alloxan-glucose interaction: effect on incorporation of 14C-leucine into pancreatic islets of rat.

Authors:  R Bansal; N Ahmad; J R Kidwai
Journal:  Acta Diabetol Lat       Date:  1980 Apr-Jun

9.  Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro.

Authors:  K Grankvist; S Marklund; J Sehlin; I B Täljedal
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

10.  Effects in vitro of alloxan on the glucose metabolism of mouse pancreatic B-cells.

Authors:  L A Borg; S J Eide; A Andersson; C Hellerström
Journal:  Biochem J       Date:  1979-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.